Intellia Therapeutics - Global Health Economics and Outcomes Research Postdoctoral Research Fellow

Northeastern University Pharmaceutical Industry Fellowships Programis a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.

D. graduates. Akey element of the program's success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry.

Fellows have the opportunity to work closely with our innovativebiopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities.

In partnership with Northeastern University, Intellia Therapeutics is offering a two-year Health economics and outcomes research (HEOR) fellowship, based in Cambridge, MA.

Intellia Therapeutics is a Cambridge-based biotechnology company focused on developing clustered regularly interspaced shortpalindromic repeats (CRISPR)-based gene editing therapies to transform lives of people with severe diseases. In fact, Intellia'sco-founder Jennifer Doudna along with Emmanuelle Charpentier wereawarded the 2020 Nobel Prize in Chemistry for their pioneering workin CRISPR.

At Intellia, we are humbled to contribute to what we believe to bemedical history. As a leader in this field, our responsibility and commitment to patients is critical in our pursuit of developing novel, potentially curative therapeutics utilizing CRISPR-based technologies.

More specifically, we are employing a modular gene editing platform to create diverse in vivo and ex vivo therapeutics, spanning arange of disease indications. Guided by this full-spectrumapproach, we are committed to making CRISPR-based medicines areality for people living with genetic diseases and to creatingnovel engineered cell therapies for various cancers and autoimmune diseases.

Northeastern University Pharmaceutical Industry Fellowships Programis a 2-year experiential program designed to advance lifelong learning and the education and training of PharmD/MPH/PhDgraduates. A key element of the program's success is preparing

Fellows to meet evolving workforce needs across various sectors ofthe pharmaceutical industry. Fellows have the opportunity to work closely with our innovative biopharmaceutical industry partners,while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Intellia Therapeutics is offering a 2-year Global HEOR and Evidence Strategyfellowship, based in Cambridge, MA.

During the program, Fellows will work collaboratively andcross-functionally in Intellia's HEOR and Evidence Strategy team,gaining exposure to our high-energy, fast-paced, and supportive culture. The HEOR and Evidence Strategy team sits within the Market Access and Patient Services team in the Commercial Organization. AtIntellia, a technical and scientific expertise background is highly valued. The Fellowship offers a uniquely structured experience,beginning with a foundational year working with the Director, HEORand Evidence Strategy supporting the HEOR strategy for Intellia'snovel, gene-editing therapies.

This foundational year provides the Fellow with a strong understanding of strategic development ofvalue and evidence generation strategy to support clinical development and commercial brand plans. In the second year, the Fellow will have an option to participate in 1-3 projects /activities within the broader Market Access and Patient Service steam. These optional activities will aim to give the Fellowexposure to key strategic or execution activities that fall within

Field HEOR and Market Access Strategy. This will allow the Fellowto gain blended exposure across Intellia's dynamic business functions and build a versatile skill set for a future inbiotech.

• DEVELOP in-depth knowledge of Intellia's CRISPR gene editingtechnology, disease and treatment landscape of relevant therapeutic areas-to support strategic evidence generation to support the product value proposition
• LEARN to execute global/US HEOR studies which span across thekey scientific pillars including;
• Patient-focused drug development including patient-reported outcomes as key measures in clinical trials
• Real-world evidence generation and analysis to identify…